IMA unveils its all-in-one solutions for pharmaceutical at CPHI

The Pharmaceutical and MedTech Divisions of IMA Group, together with their specialists, will introduce the All-In-One supplier specialized in designing and manufacturing innovative machines and complete lines for the packaging and processing of pharmaceutical, nutraceutical and medical products.

Following its world premiere at Achema 2024 and recent display at Interphex NY 2025, IMA Life will showcase TILE-X, a revolutionary, fully gloveless solution for the filling and closing of small-batch Ready-To-Use (RTU) production. Developed in compliance with Annex 1 of the GMP guidelines, TILE-X is specifically designed for high-value products such as personalized medicines, cell & gene therapies, and ATMPs. This modular concept handles a wide variety of RTU containers – syringes, vials, and cartridges – using electromagnetic motion technology to ensure precise, frictionless operation in a 100% gloveless environment. Both the filling nozzle changeover and the replacement of single-use microbial impactors are fully automated, ensuring maximum sterility and operator safety. TILE-X recently received the Biotech Innovation Award at Interphex NY 2025. 

Continuous Manufacturing underpins the improvement of pharmaceutical products in terms of potency, effectiveness and safety by means of accurate process control. IMA Active has been cultivating their own knowledge and are ready to welcome the demand for innovation, working together with companies and stakeholders to design the future of pharmaceutical manufacturing and taking the lead in the future of pharmaceutical technologies for OSD (Oral Solid Dosage) forms. IMA Active’s belief in and knowledge of Continuous Manufacturing have grown stronger thanks to intensive R&D work carried out on two fronts.

A more disruptive front of IMA Active R&D consists in the partnership with Continuus Pharmaceuticals, a spin out of Novartis MIT centre. While on the other R&D front IMA Active works on continuous processes by revisiting current technologies, embracing a concept of Continuous Manufacturing more closely related to conventional solid forms. IMA Active proposes Continuous Manufacturing lines for compression and coating of OSD forms as a single partner of integrated solutions based on flexibility and modularity. At this year’s CPHI edition, a dedicated Continuous Manufacturing corner powered by Continuus Pharmaceuticals will also be on display.

The X-PEN, powered by IMA MED-TECH and available on virtual display, is a versatile modular platform for the final assembly of pen injectors and autoinjectors. The X-PEN portfolio offers flexible solutions ranging from manual to fully automated systems, meeting the needs of diverse production environments with output speeds from 2 to 160 ppm. Designed for both pre-assembly and final assembly, X-PEN integrates automated quality controls, including force-distance measurements and vision inspection, ensuring optimal precision and product integrity. The platform is ideal for assembling devices used in the treatment of conditions like diabetes, obesity, and multiple sclerosis, among others.